{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T05:49:46Z","timestamp":1772084986737,"version":"3.50.1"},"reference-count":27,"publisher":"Japanese Association for Laboratory Animal Science","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp. Anim."],"published-print":{"date-parts":[[2022]]},"DOI":"10.1538\/expanim.22-0012","type":"journal-article","created":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T22:11:17Z","timestamp":1652393477000},"page":"442-450","source":"Crossref","is-referenced-by-count":7,"title":["The establishment and application of CD3E humanized mice in immunotherapy"],"prefix":"10.1538","volume":"71","author":[{"given":"Rufeng","family":"Zhang","sequence":"first","affiliation":[{"name":"College of life science and technology, Beijing University of Chemical Technology, 15 Beisanhuan East Road, Chaoyang District, Beijing 100029, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Biocytogen Pharmaceuticals (Beijing) Co., Ltd., 12 Baoshen South Street, Daxing District,102609, Beijing, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofei","family":"Zhou","sequence":"additional","affiliation":[{"name":"Biocytogen Pharmaceuticals (Beijing) Co., Ltd., 12 Baoshen South Street, Daxing District,102609, Beijing, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Biocytogen Pharmaceuticals (Beijing) Co., Ltd., 12 Baoshen South Street, Daxing District,102609, Beijing, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changyuan","family":"Yu","sequence":"additional","affiliation":[{"name":"College of life science and technology, Beijing University of Chemical Technology, 15 Beisanhuan East Road, Chaoyang District, Beijing 100029, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"439","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Dong D, Zheng L, Lin J, Zhang B, Zhu Y, Li N, et al. Structural basis of assembly of the human T cell receptor-CD3 complex. Nature. 2019; 573: 546\u2013552.","DOI":"10.1038\/s41586-019-1537-0"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Call ME, Wucherpfennig KW. Molecular mechanisms for the assembly of the T cell receptor-CD3 complex. Mol Immunol. 2004; 40: 1295\u20131305.","DOI":"10.1016\/j.molimm.2003.11.017"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Barber EK, Dasgupta JD, Schlossman SF, Trevillyan JM, Rudd CE. The CD4 and CD8 antigens are coupled to a protein-tyrosine kinase (p56lck) that phosphorylates the CD3 complex. Proc Natl Acad Sci USA. 1989; 86: 3277\u20133281.","DOI":"10.1073\/pnas.86.9.3277"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Alarc\u00f3n B, Gil D, Delgado P, Schamel WW. Initiation of TCR signaling: regulation within CD3 dimers. Immunol Rev. 2003; 191: 38\u201346.","DOI":"10.1034\/j.1600-065X.2003.00017.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Borroto A, Lama J, Niedergang F, Dautry-Varsat A, Alarc\u00f3n B, Alcover A. The CD3 epsilon subunit of the TCR contains endocytosis signals. J Immunol. 1999; 163: 25\u201331.","DOI":"10.4049\/jimmunol.163.1.25"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Martin-Blanco N, Jim\u00e9nez Teja D, Bretones G, Borroto A, Caraballo M, Screpanti I, et al. CD3\u03b5 recruits Numb to promote TCR degradation. Int Immunol. 2016; 28: 127\u2013137.","DOI":"10.1093\/intimm\/dxv060"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Dave VP, Cao Z, Browne C, Alarcon B, Fernandez-Miguel G, Lafaille J, et al. CD3 delta deficiency arrests development of the alpha beta but not the gamma delta T cell lineage. EMBO J. 1997; 16: 1360\u20131370.","DOI":"10.1093\/emboj\/16.6.1360"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Haks MC, Krimpenfort P, Borst J, Kruisbeek AM. The CD3gamma chain is essential for development of both the TCRalphabeta and TCRgammadelta lineages. EMBO J. 1998; 17: 1871\u20131882.","DOI":"10.1093\/emboj\/17.7.1871"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Shores EW, Huang K, Tran T, Lee E, Grinberg A, Love PE. Role of TCR zeta chain in T cell development and selection. Science. 1994; 266: 1047\u20131050.","DOI":"10.1126\/science.7526464"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. DeJarnette JB, Sommers CL, Huang K, Woodside KJ, Emmons R, Katz K, et al. Specific requirement for CD3epsilon in T cell development. Proc Natl Acad Sci USA. 1998; 95: 14909\u201314914.","DOI":"10.1073\/pnas.95.25.14909"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Malissen M, Gillet A, Ardouin L, Bouvier G, Trucy J, Ferrier P, et al. Altered T cell development in mice with a targeted mutation of the CD3-epsilon gene. EMBO J. 1995; 14: 4641\u20134653.","DOI":"10.1002\/j.1460-2075.1995.tb00146.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kimiz-Gebologlu I, Gulce-Iz S, Biray-Avci C. Monoclonal antibodies in cancer immunotherapy. Mol Biol Rep. 2018; 45: 2935\u20132940.","DOI":"10.1007\/s11033-018-4427-x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Thomas A, Teicher BA, Hassan R. Antibody-drug conjugates for cancer therapy. Lancet Oncol. 2016; 17: e254\u2013e262.","DOI":"10.1016\/S1470-2045(16)30030-4"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Aryee KE, Shultz LD, Brehm MA. Immunodeficient mouse model for human hematopoietic stem cell engraftment and immune system development. Methods Mol Biol. 2014; 1185: 267\u2013278.","DOI":"10.1007\/978-1-4939-1133-2_18"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Rongvaux A, Takizawa H, Strowig T, Willinger T, Eynon EE, Flavell RA, et al. Human hemato-lymphoid system mice: current use and future potential for medicine. Annu Rev Immunol. 2013; 31: 635\u2013674.","DOI":"10.1146\/annurev-immunol-032712-095921"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Shultz LD, Brehm MA, Garcia-Martinez JV, Greiner DL. Humanized mice for immune system investigation: progress, promise and challenges. Nat Rev Immunol. 2012; 12: 786\u2013798.","DOI":"10.1038\/nri3311"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Manz MG. Human-hemato-lymphoid-system mice: opportunities and challenges. Immunity. 2007; 26: 537\u2013541.","DOI":"10.1016\/j.immuni.2007.05.001"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Olson B, Li Y, Lin Y, Liu ET, Patnaik A. Mouse Models for Cancer Immunotherapy Research. Cancer Discov. 2018; 8: 1358\u20131365.","DOI":"10.1158\/2159-8290.CD-18-0044"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Wang B, Biron C, She J, Higgins K, Sunshine MJ, Lacy E, et al. A block in both early T lymphocyte and natural killer cell development in transgenic mice with high-copy numbers of the human CD3E gene. Proc Natl Acad Sci USA. 1994; 91: 9402\u20139406.","DOI":"10.1073\/pnas.91.20.9402"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Liu Y, He Y, Zhang J, Jiang L, Liu S, Zheng D. Tyrosine mutation in CD3epsilon-ITAM blocked T lymphocyte apoptosis mediated by CD3epsilon. Immunol Invest. 2003; 32: 59\u201370.","DOI":"10.1081\/IMM-120019208"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Varadhachary AS, Perdow SN, Hu C, Ramanarayanan M, Salgame P. Differential ability of T cell subsets to undergo activation-induced cell death. Proc Natl Acad Sci USA. 1997; 94: 5778\u20135783.","DOI":"10.1073\/pnas.94.11.5778"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Sugita S, Shimizu J, Makabe K, Keino H, Watanabe T, Takahashi M. Inhibition of T cell-mediated inflammation in uveitis by a novel anti-CD3 antibody. Arthritis Res Ther. 2017; 19: 176.","DOI":"10.1186\/s13075-017-1379-9"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Bacac M, Fauti T, Sam J, Colombetti S, Weinzierl T, Ouaret D, et al. A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors. Clin Cancer Res. 2016; 22: 3286\u20133297.","DOI":"10.1158\/1078-0432.CCR-15-1696"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Gaglia J, Kissler S. Anti-CD3 Antibody for the Prevention of Type 1 Diabetes: A Story of Perseverance. Biochemistry. 2019; 58: 4107\u20134111.","DOI":"10.1021\/acs.biochem.9b00707"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Shiraiwa H, Narita A, Kamata-Sakurai M, Ishiguro T, Sano Y, Hironiwa N, et al. Engineering a bispecific antibody with a common light chain: Identification and optimization of an anti-CD3 epsilon and anti-GPC3 bispecific antibody, ERY974. Methods. 2019; 154: 10\u201320.","DOI":"10.1016\/j.ymeth.2018.10.005"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Wu W, Zhou Q, Masubuchi T, Shi X, Li H, Xu X, et al. Multiple Signaling Roles of CD3\u03b5 and Its Application in CAR-T Cell Therapy. Cell. 2020; 182: 855\u2013871.e23.","DOI":"10.1016\/j.cell.2020.07.018"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Ueda O, Wada NA, Kinoshita Y, Hino H, Kakefuda M, Ito T, et al. Entire CD3\u03b5, \u03b4, and \u03b3 humanized mouse to evaluate human CD3-mediated therapeutics. Sci Rep. 2017; 7: 45839.","DOI":"10.1038\/srep45839"}],"container-title":["Experimental Animals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/expanim\/71\/4\/71_22-0012\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,5]],"date-time":"2023-02-05T02:25:07Z","timestamp":1675563907000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/expanim\/71\/4\/71_22-0012\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1538\/expanim.22-0012","relation":{},"ISSN":["1341-1357","1881-7122"],"issn-type":[{"value":"1341-1357","type":"print"},{"value":"1881-7122","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"22-0012"}}